| abstract |
The invention relates generally to antibodies, activatable antibodies, multispecific nantibodies, and multispecific activatable antibodies that specifically bind to at least CD3, as nwell as to methods of making and using these antibodies, activatable antibodies, multispecific nantibodies, and/or multispecific activatable antibodies in a variety of therapeutic, diagnostic nand prophylactic indications. |